NEW YORK (GenomeWeb News) – Laboratory Corporation of America is planning on expanding its portfolio of genomics-based diagnostics, CEO David King said this week at the JP Morgan Healthcare Conference.

"We never want to get away from the core [testing] business, because the core business is very fundamental to the delivery of healthcare and to patient care," King said in his presentation, which was webcast. "But we want to migrate the business to where we can continue to be seen as a value adder in the value chain."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.